Clinical trial to examine the safety of early removal of chest tube after thoracic surgery

Phase 2

• Conditions: Diseases scheduled for thoracic surgery

• Registration Number: JPRN-UMIN000044057
• Lead Sponsor: Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-27
• Study Completion: 2023-04-27
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 151

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients scheduled for surgery with resection of the lung parenchyma show severe emphysematous changes and interstitial lung disease in the remaining lungs on preoperative imaging. 2. Patients who require combined resection and / or reconstruction of adjacent organs / structures such as the rib cage and diaphragm. 3. Patients who require continuous chest tube drainage after surgery, such as empyema. 4. Patients with high-risk factors for bleeding (patients with hemorrhagic disease, patients taking antithrombotic / anticoagulant) or with chest trauma that require observation of postoperative bleeding. 5. Other patients whose participation in this study was judged to be inappropriate by the surgeon.

Study & Design

• Study Type: Interventional
• Study Design: Not specified